Safety panel backs principle of gene-therapy trials.
Check
Erika
E
D002648:Child; D026661:Clinical Trials Data Monitoring Committees / Q000331:legislation & jurisprudence*; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000331:legislation & jurisprudence* / Q000592:standards; D005602:France; D015316:Genetic Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence* / Q000592:standards; D006801:Humans; D007938:Leukemia / Q000209:etiology / Q000235:genetics; D008297:Male; D008991:Monitoring, Physiologic; D009316:National Institutes of Health (U.S.) / Q000331:legislation & jurisprudence; D017410:Practice Guidelines as Topic; D016511:Severe Combined Immunodeficiency / Q000235:genetics* / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence